New CRISPR screen identifies key regulators of anterior neural tube closure

Human embryonic development, particularly the intricate process of neural tube formation, is a highly orchestrated event. Failures in this process lead to neural tube defects (NTDs), a group of severe birth anomalies that include anencephaly and spina bifida. While folate supplementation has reduced the incidence of some NTDs, the underlying genetic architecture for many anterior neural tube closure defects remains poorly understood. This knowledge gap stems largely from the ethical and practical difficulties of studying human embryogenesis directly, pushing researchers to seek alternative models that can faithfully recapitulate early developmental stages.¹

Researchers at the University of California, San Francisco, led by Dr. Rebecca Huang, developed a platform to address these challenges. They utilized hPSC-derived organoids, which offer a powerful in vitro model for studying human embryonic morphogenesis. The team specifically focused on creating a reproducible organoid model of anterior neurulation, the process by which the anterior part of the neural tube closes to form the forebrain. This model allowed for the systematic perturbation of single genes, a critical step for identifying specific genetic drivers of developmental processes.¹

Overcoming variability in organoid screening

The primary hurdle in using organoids for high-throughput genetic screening has been their inherent variability and the high cost associated with performing scaled tissue-wide single-gene perturbations. Huang and colleagues engineered a platform that integrates reproducible organoid morphogenesis with uniform single-gene perturbations, making arrayed CRISPR interference (CRISPRi) screening feasible in hPSC-derived organoids. This innovation allowed for the simultaneous assessment of multiple genetic targets in a controlled and scalable manner.¹

The platform’s design focused on minimizing batch-to-batch variability, a common issue in organoid research. They optimized culture conditions and differentiation protocols to ensure consistent formation of anterior neural tube-like structures. This consistency was crucial for accurately interpreting the effects of genetic perturbations, as it reduced confounding factors related to inherent differences in organoid development. The ability to generate uniform organoids meant that observed phenotypic changes could be more confidently attributed to the targeted gene knockdown.¹

Identifying key transcription factors

To demonstrate the utility of their platform, the researchers screened 77 transcription factors known or suspected to play roles in neural development. They applied CRISPRi to systematically repress the expression of each target gene within the hPSC-derived anterior neural organoids. The primary endpoint for this screen was the assessment of neural tube closure morphology, specifically looking for defects or abnormalities in the formation of the anterior neural tube structures.¹

The screen successfully identified three essential regulators of neural tube closure: ZIC2, SOX11, and ZNF521. These transcription factors emerged as critical players in the complex genetic program governing forebrain development. The identification of these specific genes provides concrete targets for further investigation into the etiology of anterior neural tube defects.¹

Distinct roles in neural tube formation

The study elucidated the distinct, yet interconnected, roles of these identified transcription factors. ZIC2 and SOX11 were found to be required for neural tube closure. When the expression of either ZIC2 or SOX11 was suppressed using CRISPRi, the organoids consistently exhibited severe defects in neural tube closure, failing to form the characteristic closed structures. This indicates that both genes are indispensable for the physical process of the neural tube fusing.¹

Conversely, ZNF521 played an opposing role, actively preventing ectopic closure points. When ZNF521 expression was knocked down, the organoids displayed aberrant, premature, or multiple closure points, suggesting that ZNF521 acts as a crucial brake on the closure process, ensuring it occurs at the correct time and location. This regulatory balance between promoting and inhibiting closure is vital for proper morphogenesis.¹

Transcriptomic insights into gene regulation

To further dissect the molecular mechanisms, the team performed single-cell transcriptomic analysis on perturbed organoids. This allowed them to identify co-regulated gene targets of ZIC2 and SOX11, revealing a shared gene regulatory program. The analysis showed that ZIC2 and SOX11 likely work in concert to activate a network of genes essential for the cellular processes underlying neural tube fusion. This includes genes involved in cell adhesion, migration, and proliferation, all critical for the dynamic changes required during closure.¹

The transcriptomic data also reinforced the opposing role of ZNF521. Its knockdown led to a distinct gene expression profile, consistent with its function in preventing ectopic closure. This suggests that ZNF521 might repress genes that, if overexpressed, would drive premature or mislocalized closure events. The intricate interplay between these three transcription factors highlights a finely tuned genetic circuit governing anterior neural tube development.¹

Implications for developmental biology and clinical practice

This single-gene perturbation platform represents a significant advance for high-throughput genetic screening in human embryonic morphogenesis models. The ability to systematically identify genetic drivers in a controlled in vitro environment opens new avenues for understanding congenital disorders. For clinicians, this research provides a deeper mechanistic understanding of anterior neural tube defects, moving beyond descriptive epidemiology to specific genetic pathways.¹

The identification of ZIC2, SOX11, and ZNF521 as key regulators offers potential diagnostic markers for NTDs. Future research could explore whether mutations or dysregulation in these genes correlate with specific types of anterior neural tube defects observed in patients. This could lead to improved genetic counseling and prenatal diagnostic strategies. The Oxford Handbook of Genetics provides a comprehensive overview of how such genetic insights translate into clinical practice.¹

Caveats and future directions

While the organoid model offers unparalleled access to human embryonic processes, it is still an in vitro system and does not fully recapitulate the complexity of the whole embryo. The absence of maternal-fetal interactions, vascularization, and systemic signaling pathways means that some regulatory nuances might be missed. Still, the model's reproducibility and scalability make it an invaluable tool for initial gene discovery.¹

The study focused on 77 transcription factors, a targeted but not exhaustive list. Future screens could expand to include a broader range of genetic elements, including non-coding RNAs or epigenetic regulators, to uncover additional drivers of neural tube closure. The current findings establish a strong foundation, but the full genetic landscape of NTDs is undoubtedly more complex. Further validation in animal models or human genetic cohorts will be essential to confirm the clinical relevance of these findings.¹

The platform's utility extends beyond neural tube closure. It could be adapted to study other aspects of human embryonic morphogenesis, such as heart development, limb formation, or craniofacial patterning. This versatility makes it a powerful tool for developmental biology, potentially accelerating the discovery of genetic causes for a wide range of congenital anomalies. The ability to precisely perturb single genes and analyze their effects at a single-cell level represents a significant leap forward in understanding early human development.¹